| Johanna Rodriguez, MSN, FNP-BC | |
|
62 Albin Rd, Bow, NH 03304-3707 | |
| (603) 703-9622 | |
| Not Available |
| Full Name | Johanna Rodriguez |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 62 Albin Rd, Bow, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629691894 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | PENDING (New Hampshire) | Primary |
| Entity Name | Lawrence Family Doctors Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295853927 PECOS PAC ID: 6002859600 Enrollment ID: O20050606000136 |
News Archive
Porvair Filtration Group has announced the launch of the first product, a ChIP kit containing 24 assays, based upon its novel Chromatrap™ Pro-A Chromatin ImmunoPrecipitation (ChIP) technology. The exciting new product has been enthusiastically tested at 12 beta sites around the world with excellent results and feedback.
Patients advised to lose weight by their physicians dropped more pounds on average than those who didn't receive a recommendation, according to new research from the University of Georgia published in the journal Economics & Human Biology.
nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, today announced the initiation of a feasibility clinical trial designed to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF). This prospective, feasibility study will enroll patients at study sites across the United States.
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine.
Adamis Pharmaceuticals Corporation, today announced the technology which constitutes its compound APC-100 was recently granted a patent in the United States.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Johanna Rodriguez, MSN, FNP-BC 62 Albin Rd, Bow, NH 03304-3707 Ph: (603) 703-9622 | Johanna Rodriguez, MSN, FNP-BC 62 Albin Rd, Bow, NH 03304-3707 Ph: (603) 703-9622 |
News Archive
Porvair Filtration Group has announced the launch of the first product, a ChIP kit containing 24 assays, based upon its novel Chromatrap™ Pro-A Chromatin ImmunoPrecipitation (ChIP) technology. The exciting new product has been enthusiastically tested at 12 beta sites around the world with excellent results and feedback.
Patients advised to lose weight by their physicians dropped more pounds on average than those who didn't receive a recommendation, according to new research from the University of Georgia published in the journal Economics & Human Biology.
nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, today announced the initiation of a feasibility clinical trial designed to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF). This prospective, feasibility study will enroll patients at study sites across the United States.
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine.
Adamis Pharmaceuticals Corporation, today announced the technology which constitutes its compound APC-100 was recently granted a patent in the United States.
› Verified 4 days ago